The most comprehensive lab focused on ALS/Lou Gehrig's Disease. We are the Drug Discovery Engine discovering & inventing effective treatments for ALS. #EndALS
Today, we honor Lou Gehrig, whose legacy continues to inspire the fight against ALS.
As we remember Lou, we also recognize the progress made possible by researchers, participants, advocates, and supporters working toward a future without ALS.
Looking for a way to make an impact this June? 💙
Join us at one of our upcoming events, including community fundraisers, educational programs, Kids Quest to Cure ALS, The ALS 100, and the Tri-State Trek.
Check out what's happening this month: https://t.co/vuPuQYVgFz
As ALS Awareness Month comes to a close, thank you to everyone who shared, advocated, fundraised, & supported ALS research.
Awareness Month may be ending, but the work continues. Every day, our community comes together with one goal: ending ALS.
Thank you for driving progress.
Why do certain populations face a higher risk of ALS?
Champion Insights is studying elite athletes, veterans, and first responders to better understand how genetics, environment, and lifestyle may influence ALS risk and progression.
Watch more: https://t.co/Mb3dGpJxtZ
There are more potential ALS therapies than ever before, but moving them forward takes infrastructure, testing, & translational research.
At ALS TDI, discovery through translation happens under one roof to help evaluate therapies faster. Learn more: https://t.co/Fo7h0dJhd7
Yesterday, Stuart Chapin began a 3,000+ mile ride across the country in honor of his father, who passed away from ALS.
Now through August, he’ll ride from NYC to San Francisco to raise funds for ALS research at ALS TDI.
Read his story: https://t.co/zXwKfcvdco
ALS is not a single disease. Researchers believe it involves multiple biological pathways and likely different subtypes.
At ALS TDI, we study these differences across models, datasets, and patient-derived samples to help support more targeted approaches to treatment.
ALS progression looks different for every person living with it. Through the ARC Study, ALS TDI is collecting clinical, biological, and digital data over time to better understand how ALS changes in individuals.
Better data can help guide better trials: https://t.co/Gozfy6TfBn
Step up to the plate for Lou Gehrig Day ⚾
Our limited-edition ALS TDI baseball shirt is available now for $30. Order soon to receive yours before June 2!
🛒 https://t.co/rXtiXAnSqq
ALS research has reached a turning point.
ALS TDI is expanding our scientific team and building a new 33,000 sq. ft. lab to test more ideas, move faster, and help advance more potential treatments toward clinical trials.
Follow along for updates on this landmark expansion.
Honored to announce Team ALS TDI / @Google Co-Scientist received a #LongitudePrizeOnALS Discovery Award! We'll use advanced AI to find new drug targets and move closer to real treatments.
@mndassociation@ChallengeWorks
Learn more: https://t.co/bZp0LGLJmr
ALS is a progressive disease that damages nerve cells that send signals from the brain to muscles. As communication breaks down, people experience muscle weakness, loss of movement, & paralysis.
Our team is working to understand these breakdowns & move research forward faster.
May is ALS Awareness Month, and we’ve got a great lineup of events to support ALS research. Join us and be part of what moves research forward → https://t.co/RCbzl4RLZ2
May is ALS Awareness Month—a time to recognize ALS’s impact and urgency to move research forward. At ALS TDI, we turn promising ideas into potential treatments. Progress depends on participation, partnership, & community.
Follow along to learn more → https://t.co/Fo7h0dJhd7
Our Fight ALS Film Fest returns for year 5—kicking off ALS Awareness Month.
5 powerful films + special guests from each story. Sunny of Sunnystrong and Her ALS Story returns as emcee.
Learn more & register: https://t.co/G8pLAk6R1E
What does ALS TDI’s expansion mean—and why now?
Dr. Fernando Vieira shares how growing our team and research capacity will help test more ideas and move potential treatments forward faster.
We have the experience, the plan, and we’re ready for what comes next. Stay tuned.
This means more therapies tested, faster progress, and fewer promising ideas left behind.
Made possible by Augie's Quest to Cure ALS and supporters like you.
Read more: https://t.co/3zfuHq4Fga
(2/2)
ALS research has reached a turning point.
More ideas than ever—but too few places can turn them into treatments.
To meet this moment, ALS TDI is expanding: doubling our research team and building a new 33,000 sq. ft. lab.
(1/2)
ALS research has reached a turning point.
On Thursday, ALS TDI CEO and CSO, Fernando Vieira will share how ALS TDI is meeting this moment—and what it means for people living with ALS.